All News

Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc.
Ref: PR Newswire
Tags: Press ReleaseNeuropharm Corporate Affairs Mergers & Acquisitions
ViewPoints: Roche readies haemophilia A gene therapy for late stage testing
Ref: ViewPoints Desk
Tags: ViewPointsRoche Spark Therapeutics BioMarin Clinical Research (R&D)SPK-8011 valoctocogene roxaparvovec
SOTIO Announces First Patient Dosed in Part B of Phase 1/1b Study with SO-C101 in Combination with Pembrolizumab in Patients with Solid Tumors
Ref: GlobeNewswire
Tags: Press ReleaseCytune Pharma SOTIO Clinical Research (R&D)pembrolizumab SO-C101
Akebia Announces Initiation of Investigator-Sponsored Study Evaluating Vadadustat for Prevention and Treatment of ARDS in Patients Hospitalized with COVID-19
Ref: PR Newswire
Tags: Press ReleaseAkebia TherapeuticsCOVID-19 ARDS Clinical Research (R&D)vadadustat
NICE Partners with Flatiron Health to Develop Real-World Evidence Research Methodologies
Ref: Business Wire
Tags: Press ReleaseFlatiron Health NICECorporate Affairs
Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia
Ref: PR Newswire
Tags: Press ReleaseDomainex Invivoscribe TherapeuticsLeukaemias Corporate Affairs Licensing
EyeGate Pharma to Proceed with PE Pivotal Study
Ref: Accesswire
Tags: Press ReleaseEyeGate FDARegulatory Affairs
Arch Biopartners Engages Global CRO to Conduct LSALT peptide (Metablok) Phase II trial for Treatment of Complications in COVID-19 Patients in the U.S.
Ref: GlobeNewswire
Tags: Press ReleaseArch BiopartnersCOVID-19 Clinical Research (R&D)Metablok
Hackensack Meridian CDI has Struck a COVID-19 Research Collaboration with Merck
Ref: PR Newswire
Tags: Press ReleaseMerck & Co.COVID-19 Corporate Affairs
DUPIXENT (dupilumab) receives positive recommendation from INESSS for the treatment of moderate-to-severe atopic dermatitis in adolescents
Ref: CNW
Tags: Press ReleaseRegeneron SanofiDermatitis Marketing & SalesDupixent